http://hl7.org/fhir/uv/ebm/Citation/179623
type: Citation
node role: treeRoot
id:
  v: 179623
meta:
  version id:
    v: 21
  last updated:
    v: 2025-10-13T12:34:35.118Z
  profile:
    v: http://hl7.org/fhir/uv/ebm/StructureDefinition/journal-article-citation
    l: journal-article-citation
language:
  v: en
text:
  status:
    v: extensions
  div:
    v: Generated Narrative: Citation 179623 version: 21; Last updated: 2025-10-13 12:34:35+0000; Language: en Profile: JournalArticleCitation ArtifactPublicationStatus: Active url: https://fevir.net/resources/Citation/179623 identifier: FEvIR Object Identifier/179623, https://pubmed.ncbi.nlm.nih.gov/23452809 title: 23452809 Long-term follow-up of a phase II trial of chemotherapy plus hormone therapy for biochemical relapse after definitive local therapy for prostate cancer. status: Active author: Computable Publishing®: MEDLINE-to-FEvIR Converter: publisher: Computable Publishing LLC contact: support@computablepublishing.com description: This Citation Resource is referenced in an example for the EBMonFHIR Implementation Guide. UseContexts - Code Value[x] * Citation Classification Type: fevir-platform-use (FEvIR Platform Use) Medline Base copyright: https://creativecommons.org/licenses/by-nc-sa/4.0/ approvalDate: 2013-04-22 lastReviewDate: 2021-10-21 classification type: Citation Source classifier: MEDLINE classification type: MEDLINE Citation Owner classifier: National Library of Medicine, Index Section currentState: Medline Citation Status of Medline, PubMed PublicationStatus of ppublish statusDate activity: PubMed Pubstatus of Received period: ?? --> 2012-11-21 statusDate activity: PubMed Pubstatus of Revised period: ?? --> 2012-12-14 statusDate activity: PubMed Pubstatus of Accepted period: ?? --> 2012-12-18 statusDate activity: PubMed Pubstatus of Entrez period: ?? --> 2013-03-05 06:00:00+0000 statusDate activity: PubMed Pubstatus of Pubmed period: ?? --> 2013-03-05 06:00:00+0000 statusDate activity: PubMed Pubstatus of Medline period: ?? --> 2013-04-23 06:00:00+0000 citedArtifact identifier: https://pubmed.ncbi.nlm.nih.gov/23452809, https://doi.org/10.1016/j.urology.2012.12.025, pii/S0090-4295(12)01569-5 Titles - Type Text * Primary title Long-term follow-up of a phase II trial of chemotherapy plus hormone therapy for biochemical relapse after definitive local therapy…
contained: Practitioner
  id:
    v: contributor0
  name:
    family:
      v: Nakabayashi
    given:
      v: Mari
contained: Practitioner
  id:
    v: contributor1
  name:
    family:
      v: Xie
    given:
      v: Wanling
contained: Practitioner
  id:
    v: contributor2
  name:
    family:
      v: Buckle
    given:
      v: Geoffrey
contained: Practitioner
  id:
    v: contributor3
  name:
    family:
      v: Bubley
    given:
      v: Glenn
contained: Practitioner
  id:
    v: contributor4
  name:
    family:
      v: Ernstoff
    given:
      v: Marc S
contained: Practitioner
  id:
    v: contributor5
  name:
    family:
      v: Walsh
    given:
      v: William
contained: Practitioner
  id:
    v: contributor6
  name:
    family:
      v: Morganstern
    given:
      v: Daniel E
contained: Practitioner
  id:
    v: contributor7
  name:
    family:
      v: Kantoff
    given:
      v: Philip W
contained: Practitioner
  id:
    v: contributor8
  name:
    family:
      v: Taplin
    given:
      v: Mary-Ellen
contained: ArtifactAssessment
  id:
    v: meshHeading0
  artifact: Reference
    l: #
    reference:
      v: #
    type:
      v: Citation
      l: Citation
  content:
    type:
      text:
        v: components (if present) include qualifier codings
    classifier:
      coding: D000368
    free to share:
      v: true
  content:
    type:
      text:
        v: components (if present) include qualifier codings
    classifier:
      coding: D000726
    free to share:
      v: true
    component:
      classifier:
        coding: Q000627
  content:
    type:
      text:
        v: components (if present) include qualifier codings
    classifier:
      coding: D000813
    free to share:
      v: true
    component:
      classifier:
        coding: Q000627
  content:
    type:
      text:
        v: components (if present) include qualifier codings
    classifier:
      coding: D000970
    free to share:
      v: true
    component:
      classifier:
        coding: Q000008
  content:
    type:
      text:
        v: components (if present) include qualifier codings
    classifier:
      coding: D018931
    free to share:
      v: true
    component:
      classifier:
        coding: Q000008
  content:
    type:
      text:
        v: components (if present) include qualifier codings
    classifier:
      coding: D000971
    free to share:
      v: true
    component:
      classifier:
        coding: Q000627
  content:
    type:
      text:
        v: components (if present) include qualifier codings
    classifier:
      coding: http://id.nlm.nih.gov/mesh/D000077143
    free to share:
      v: true
  content:
    type:
      text:
        v: components (if present) include qualifier codings
    classifier:
      coding: D004359
    free to share:
      v: true
  content:
    type:
      text:
        v: components (if present) include qualifier codings
    classifier:
      coding: D004961
    free to share:
      v: true
    component:
      classifier:
        coding: Q000008
  content:
    type:
      text:
        v: components (if present) include qualifier codings
    classifier:
      coding: D005500
    free to share:
      v: true
  content:
    type:
      text:
        v: components (if present) include qualifier codings

v: mesh-heading

v: MeSH heading

v: D000368

v: Aged

v: false

v: qualifier

v: is not a major topic

v: mesh-heading

v: MeSH heading

v: D000726

v: Androgen Antagonists

v: false

v: qualifier

v: is not a major topic

v: qualifier

Q000627
system:
  v: https://www.nlm.nih.gov/mesh
  l: mesh
code:
  v: Q000627
display:
  v: therapeutic use

text:
  v: is Major topic

coding:
  system:
    v: http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl
    l: Thesaurus.owl
  code:
    v: C49488
  display:
    v: Yes

v: mesh-heading

v: MeSH heading

v: D000813

v: Anilides

v: false

v: qualifier

v: is not a major topic

v: qualifier

Q000627
system:
  v: https://www.nlm.nih.gov/mesh
  l: mesh
code:
  v: Q000627
display:
  v: therapeutic use

text:
  v: is Major topic

coding:
  system:
    v: http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl
    l: Thesaurus.owl
  code:
    v: C49488
  display:
    v: Yes

v: mesh-heading

v: MeSH heading

v: D000970

v: Antineoplastic Agents

v: false

v: qualifier

v: is not a major topic

v: qualifier

Q000008
system:
  v: https://www.nlm.nih.gov/mesh
  l: mesh
code:
  v: Q000008
display:
  v: administration & dosage

text:
  v: is Major topic

coding:
  system:
    v: http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl
    l: Thesaurus.owl
  code:
    v: C49488
  display:
    v: Yes

v: mesh-heading

v: MeSH heading

v: D018931

v: Antineoplastic Agents, Hormonal

v: false

v: qualifier

v: is not a major topic

v: qualifier

Q000008
system:
  v: https://www.nlm.nih.gov/mesh
  l: mesh
code:
  v: Q000008
display:
  v: administration & dosage

text:
  v: is Major topic

coding:
  system:
    v: http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl
    l: Thesaurus.owl
  code:
    v: C49487
  display:
    v: No

v: mesh-heading

v: MeSH heading

v: D000971

v: Antineoplastic Combined Chemotherapy Protocols

v: false

v: qualifier

v: is not a major topic

v: qualifier

Q000627
system:
  v: https://www.nlm.nih.gov/mesh
  l: mesh
code:
  v: Q000627
display:
  v: therapeutic use

text:
  v: is Major topic

coding:
  system:
    v: http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl
    l: Thesaurus.owl
  code:
    v: C49488
  display:
    v: Yes

v: mesh-heading

v: MeSH heading

v: D000077143

v: Docetaxel

v: false

v: qualifier

v: is not a major topic

v: mesh-heading

v: MeSH heading

v: D004359

v: Drug Therapy, Combination

v: false

v: qualifier

v: is not a major topic

v: mesh-heading

v: MeSH heading

v: D004961

v: Estramustine

v: false

v: qualifier

v: is not a major topic

v: qualifier

Q000008
system:
  v: https://www.nlm.nih.gov/mesh
  l: mesh
code:
  v: Q000008
display:
  v: administration & dosage

text:
  v: is Major topic

coding:
  system:
    v: http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl
    l: Thesaurus.owl
  code:
    v: C49488
  display:
    v: Yes

v: mesh-heading

v: MeSH heading

v: D005500

v: Follow-Up Studies

v: false

v: qualifier

v: is not a major topic

v: mesh-heading

v: MeSH heading

coding: D017273
  system:
    v: https://www.nlm.nih.gov/mesh
    l: mesh
  code:
    v: D017273
  display:
    v: Goserelin
  user selected:
    v: false

v: true

type:
  text:
    v: qualifier
classifier:
  text:
    v: is not a major topic

type:
  text:
    v: qualifier
classifier:
  coding: Q000008
    system:
      v: https://www.nlm.nih.gov/mesh
      l: mesh
    code:
      v: Q000008
    display:
      v: administration & dosage
component:
  type:
    text:
      v: is Major topic
  classifier:
    coding:
      system:
        v: http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl
        l: Thesaurus.owl
      code:
        v: C49488
      display:
        v: Yes

type:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type
      l: cited-artifact-classification-type
    code:
      v: mesh-heading
    display:
      v: MeSH heading
  text:
    v: components (if present) include qualifier codings
classifier:
  coding: D006801
    system:
      v: https://www.nlm.nih.gov/mesh
      l: mesh
    code:
      v: D006801
    display:
      v: Humans
    user selected:
      v: false
free to share:
  v: true
component:
  type:
    text:
      v: qualifier
  classifier:
    text:
      v: is not a major topic

type:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type
      l: cited-artifact-classification-type
    code:
      v: mesh-heading
    display:
      v: MeSH heading
  text:
    v: components (if present) include qualifier codings
classifier:
  coding: D008297
    system:
      v: https://www.nlm.nih.gov/mesh
      l: mesh
    code:
      v: D008297
    display:
      v: Male
    user selected:
      v: false
free to share:
  v: true
component:
  type:
    text:
      v: qualifier
  classifier:
    text:
      v: is not a major topic

type:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type
      l: cited-artifact-classification-type
    code:
      v: mesh-heading
    display:
      v: MeSH heading
  text:
    v: components (if present) include qualifier codings
classifier:
  coding: D008875
    system:
      v: https://www.nlm.nih.gov/mesh
      l: mesh
    code:
      v: D008875
    display:
      v: Middle Aged
    user selected:
      v: false
free to share:
  v: true
component:
  type:
    text:
      v: qualifier
  classifier:
    text:
      v: is not a major topic

type:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type
      l: cited-artifact-classification-type
    code:
      v: mesh-heading
    display:
      v: MeSH heading
  text:
    v: components (if present) include qualifier codings
classifier:
  coding: D009364
    system:
      v: https://www.nlm.nih.gov/mesh
      l: mesh
    code:
      v: D009364
    display:
      v: Neoplasm Recurrence, Local
    user selected:
      v: false
free to share:
  v: true
component:
  type:
    text:
      v: qualifier
  classifier:
    text:
      v: is not a major topic
component:
  type:
    text:
      v: qualifier
  classifier:
    coding: Q000188
      system:
        v: https://www.nlm.nih.gov/mesh
        l: mesh
      code:
        v: Q000188
      display:
        v: drug therapy
  component:
    type:
      text:
        v: is Major topic

v: C49488

v: Yes

type:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type
      l: cited-artifact-classification-type
    code:
      v: mesh-heading
    display:
      v: MeSH heading
  text:
    v: components (if present) include qualifier codings
classifier:
  coding: D009570
    system:
      v: https://www.nlm.nih.gov/mesh
      l: mesh
    code:
      v: D009570
    display:
      v: Nitriles
    user selected:
      v: false
free to share:
  v: true
component:
  type:
    text:
      v: qualifier
  classifier:
    text:
      v: is not a major topic
component:
  type:
    text:
      v: qualifier
  classifier:
    coding: Q000627
      system:
        v: https://www.nlm.nih.gov/mesh
        l: mesh
      code:
        v: Q000627
      display:
        v: therapeutic use
  component:
    type:
      text:
        v: is Major topic

v: C49488

v: Yes

type:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type
      l: cited-artifact-classification-type
    code:
      v: mesh-heading
    display:
      v: MeSH heading
  text:
    v: components (if present) include qualifier codings
classifier:
  coding: D011471
    system:
      v: https://www.nlm.nih.gov/mesh
      l: mesh
    code:
      v: D011471
    display:
      v: Prostatic Neoplasms
    user selected:
      v: false
free to share:
  v: true
component:
  type:
    text:
      v: qualifier
  classifier:
    text:
      v: is not a major topic
component:
  type:
    text:
      v: qualifier
  classifier:
    coding: Q000188
      system:
        v: https://www.nlm.nih.gov/mesh
        l: mesh
      code:
        v: Q000188
      display:
        v: drug therapy
  component:
    type:
      text:
        v: is Major topic

v: C49488

v: Yes

type:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type
      l: cited-artifact-classification-type
    code:
      v: mesh-heading
    display:
      v: MeSH heading
  text:
    v: components (if present) include qualifier codings
classifier:
  coding: D012189
    system:
      v: https://www.nlm.nih.gov/mesh
      l: mesh
    code:
      v: D012189
    display:
      v: Retrospective Studies
    user selected:
      v: false
free to share:
  v: true
component:
  type:
    text:
      v: qualifier
  classifier:
    text:
      v: is not a major topic

type:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type
      l: cited-artifact-classification-type
    code:
      v: mesh-heading
    display:
      v: MeSH heading
  text:
    v: components (if present) include qualifier codings
classifier:
  coding: D043823
    system:
      v: https://www.nlm.nih.gov/mesh
      l: mesh
    code:
      v: D043823
    display:
      v: Taxoids
    user selected:
      v: false
free to share:
  v: true
component:
  type:
    text:
      v: qualifier
  classifier:
    text:
      v: is not a major topic
component:
  type:
    text:
      v: qualifier
  classifier:
    coding: Q000008
      system:
        v: https://www.nlm.nih.gov/mesh
        l: mesh
      code:
        v: Q000008
      display:
        v: administration & dosage
  component:
    type:
      text:
        v: is Major topic

v: C49488

v: Yes

type:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type
      l: cited-artifact-classification-type
    code:
      v: mesh-heading
    display:
      v: MeSH heading
  text:
    v: components (if present) include qualifier codings
classifier:
  coding: D013997
    system:
      v: https://www.nlm.nih.gov/mesh
      l: mesh
    code:
      v: D013997
    display:
      v: Time Factors
    user selected:
      v: false
free to share:
  v: true
component:
  type:
    text:
      v: qualifier
  classifier:
    text:
      v: is not a major topic

type:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type
      l: cited-artifact-classification-type
    code:
      v: mesh-heading
    display:
      v: MeSH heading
  text:
    v: components (if present) include qualifier codings
classifier:
  coding: D014105
    system:
      v: https://www.nlm.nih.gov/mesh
      l: mesh
    code:
      v: D014105
    display:
      v: Tosyl Compounds
    user selected:
      v: false
free to share:
  v: true
component:
  type:
    text:
      v: qualifier
  classifier:
    text:
      v: is not a major topic
component:
  type:
    text:
      v: qualifier
  classifier:
    coding: Q000627
      system:
        v: https://www.nlm.nih.gov/mesh
        l: mesh
      code:
        v: Q000627
      display:
        v: therapeutic use
  component:
    type:
      text:
        v: is Major topic

v: C49488

v: Yes

type:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type
      l: cited-artifact-classification-type
    code:
      v: mesh-heading
    display:
      v: MeSH heading
  text:
    v: components (if present) include qualifier codings
classifier:
  coding: D016896
    system:
      v: https://www.nlm.nih.gov/mesh
      l: mesh
    code:
      v: D016896
    display:
      v: Treatment Outcome
    user selected:
      v: false
free to share:
  v: true
component:
  type:
    text:
      v: qualifier
  classifier:
    text:
      v: is not a major topic

url:
  v: http://hl7.org/fhir/uv/ebm/StructureDefinition/artifact-publication-status
  l: artifact-publication-status
value: CodeableConcept
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/cited-artifact-status-type
      l: cited-artifact-status-type
    code:
      v: active
    display:
      v: Active

type:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/v2-0203
      l: v2-0203
    code:
      v: ACSN
    display:
      v: Accession ID
  text:
    v: FEvIR Object Identifier
system:
  v: https://fevir.net/FOI
  l: FOI
value:
  v: 179623
assigner:
  display:
    v: Computable Publishing LLC

system:
  v: https://pubmed.ncbi.nlm.nih.gov
  l: pubmed.ncbi.nlm.nih.gov
value:
  v: 23452809

v: 23452809 Long-term follow-up of a phase II trial of chemotherapy plus hormone therapy for biochemical relapse after definitive local therapy for prostate cancer.

v: active

name:
  v: Computable Publishing®: MEDLINE-to-FEvIR Converter

v: Computable Publishing LLC

telecom:
  system:
    v: email

v: This Citation Resource is referenced in an example for the EBMonFHIR Implementation Guide.

code:
  system:
    v: http://terminology.hl7.org/CodeSystem/citation-classification-type
    l: citation-classification-type
  code:
    v: fevir-platform-use
  display:
    v: FEvIR Platform Use
value: CodeableConcept
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/citation-artifact-classifier
      l: citation-artifact-classifier
    code:
      v: medline-base
    display:
      v: Medline Base
    user selected:
      v: false

v: 2013-04-22

v: 2021-10-21

type:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/citation-classification-type
      l: citation-classification-type
    code:
      v: citation-source
    display:
      v: Citation Source
classifier:
  text:
    v: MEDLINE

type:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/citation-classification-type
      l: citation-classification-type
    code:
      v: medline-owner
    display:
      v: MEDLINE Citation Owner
classifier:
  coding:
    system:
      v: https://www.nlm.nih.gov/bsd/licensee/elements_descriptions.html#owner_value
      l: owner value
    code:
      v: NLM
    display:
      v: National Library of Medicine, Index Section
    user selected:
      v: false

coding:
  system:
    v: http://hl7.org/fhir/citation-status-type
    l: citation-status-type
  code:
    v: medline-medline
  display:
    v: Medline Citation Status of Medline

coding:
  system:
    v: http://hl7.org/fhir/citation-status-type
    l: citation-status-type
  code:
    v: pubmed-publication-status-ppublish
  display:
    v: PubMed PublicationStatus of ppublish

activity:
  coding:
    system:
      v: http://hl7.org/fhir/citation-status-type
      l: citation-status-type
    code:
      v: pubmed-pubstatus-received
    display:
      v: PubMed Pubstatus of Received
period:
  end:
    v: 2012-11-21

activity:
  coding:
    system:
      v: http://hl7.org/fhir/citation-status-type
      l: citation-status-type
    code:
      v: pubmed-pubstatus-revised
    display:
      v: PubMed Pubstatus of Revised
period:
  end:
    v: 2012-12-14

activity:
  coding:
    system:
      v: http://hl7.org/fhir/citation-status-type
      l: citation-status-type
    code:
      v: pubmed-pubstatus-accepted
    display:
      v: PubMed Pubstatus of Accepted
period:
  end:
    v: 2012-12-18

activity:
  coding:
    system:
      v: http://hl7.org/fhir/citation-status-type
      l: citation-status-type
    code:
      v: pubmed-pubstatus-entrez
    display:
      v: PubMed Pubstatus of Entrez
period:
  end:
    v: 2013-03-05T06:00:00.000Z

activity:
  coding:
    system:
      v: http://hl7.org/fhir/citation-status-type
      l: citation-status-type
    code:
      v: pubmed-pubstatus-pubmed
    display:
      v: PubMed Pubstatus of Pubmed
period:
  end:
    v: 2013-03-05T06:00:00.000Z

activity:
  coding:
    system:
      v: http://hl7.org/fhir/citation-status-type
      l: citation-status-type
    code:
      v: pubmed-pubstatus-medline
    display:
      v: PubMed Pubstatus of Medline
period:
  end:
    v: 2013-04-23T06:00:00.000Z

identifier:
  system:
    v: https://pubmed.ncbi.nlm.nih.gov
    l: pubmed.ncbi.nlm.nih.gov
  value:
    v: 23452809
identifier:
  system:
    v: https://doi.org
    l: doi.org
  value:
    v: 10.1016/j.urology.2012.12.025
identifier:
  type:
    coding:
      system:
        v: http://terminology.hl7.org/CodeSystem/v2-0203
        l: v2-0203
      code:
        v: ACSN
      display:
        v: Accession ID
    text:
      v: pii
  value:
    v: S0090-4295(12)01569-5
title:
  type:
    coding:
      system:
        v: http://terminology.hl7.org/CodeSystem/title-type
        l: title-type
      code:
        v: primary
      display:
        v: Primary title
  text:
    v: Long-term follow-up of a phase II trial of chemotherapy plus hormone therapy for biochemical relapse after definitive local therapy for prostate cancer.
abstract:
  type:
    coding:
      system:
        v: http://terminology.hl7.org/CodeSystem/cited-artifact-abstract-type
        l: cited-artifact-abstract-type
      code:
        v: primary-human-use
      display:
        v: Primary human use
  text:
    v: **OBJECTIVE:** To evaluate long-term follow-up of a phase II trial of chemohormonal therapy in 62 men with prostate cancer biochemical relapse (BR). **METHODS:** Treatment was 4 cycles of docetaxel (70 mg/m(2)) every 3 weeks and estramustine 280 mg three times a day (days 1-5) followed by 15 months of goserelin acetate/bicalutamide. The primary endpoint was the proportion with prostate-specific antigen (PSA) <0.1 with recovered testosterone 5 years after completion of therapy. Secondary endpoints included time to progression (TTP), time to reinitiate androgen deprivation therapy (ADT), the proportion with castration-resistant prostate cancer (CRPC), and overall survival (OS). **RESULTS:** Median follow-up was 8.6 years (range 1.3-11.1 years). At 5 year follow-up, 7 patients (11%) had PSA <0.1 (5 undetectable); 8 (13%) had PSA >0.1 but without reinitiation of ADT (median PSA 0.37). Of the 15 (24%) men without reinitiation of ADT, and 14 have recovered testosterone to normal range. Median TTP for the complete cohort was 35.0 months (95% confidence interval [CI] 31.7-39.2). Baseline PSA <3.0 ng/dL, no prior ADT, and prostatectomy (vs radiation) were associated with longer TTP (P = .0001, P = .0055, and P = .0398, respectively). At the time of analysis, 42 men (68%) had restarted ADT, 23 men had CRPC (37%), and 11 (18%) had chemotherapy. Median time to reinitiation of ADT was 32.6 months (range 0-107.6 months). Median OS has not been reached; there were 15 deaths. **CONCLUSION:** Chemotherapy plus ADT for BR resulted in durable (>5 years) complete responses (<0.1 ng/mL) in 7 men (11%). Twenty-four percent of men have not re-initiated ADT 5 years from completion of protocol therapy.
  copyright:
    v: Copyright © 2013 Elsevier Inc. All rights reserved.
relates to:
  type:
    v: comment-in
  classifier:
    coding: D016420
      system:
        v: https://www.nlm.nih.gov/mesh
        l: mesh
      code:
        v: D016420
      display:
        v: Comment
      user selected:
        v: false
  citation:
    v: J Urol. 2013 Sep;190(3):880. doi: 10.1016/j.juro.2013.05.105.
  target: Reference
    l: https://pubmed.ncbi.nlm.nih.gov/23931194/
    reference:
      v: https://pubmed.ncbi.nlm.nih.gov/23931194/
    identifier:
      system:
        v: https://pubmed.ncbi.nlm.nih.gov
        l: pubmed.ncbi.nlm.nih.gov
      value:
        v: 23931194
publication form:
  published in:
    identifier:
      system:
        v: https://portal.issn.org
        l: portal.issn.org
      value:
        v: 1527-9995
    identifier:
      system:
        v: https://www.issn.org/services/online-services/access-to-the-ltwa/
        l: access-to-the-ltwa
      value:
        v: Urology
    identifier:
      system:
        v: https://www.issn.org/understanding-the-issn/assignment-rules/the-issn-l-for-publications-on-multiple-media/
        l: the-issn-l-for-publications-on-multiple-media
      value:
        v: 0090-4295
    identifier:
      system:
        v: https://www.nlm.nih.gov/tsd/cataloging/contructitleabbre.html
        l: contructitleabbre.html
      value:
        v: Urology
    identifier:
      system:
        v: https://locatorplus.gov/cgi-bin/Pwebrecon.cgi
        l: https://locatorplus.gov/cgi-bin/Pwebrecon.cgi
      value:
        v: 0366151
    title:
      v: Urology
    publisher location:
      v: United States
  cited medium:
    coding:
      system:
        v: http://terminology.hl7.org/CodeSystem/cited-medium
        l: cited-medium
      code:
        v: internet
      display:
        v: Internet
  volume:
    v: 81
  issue:
    v: 3
  article date:
    v: 2013-03
  page string:
    v: 611-6
web location:
  classifier:
    coding:
      system:
        v: http://terminology.hl7.org/CodeSystem/artifact-url-classifier
        l: artifact-url-classifier
      code:
        v: abstract
      display:
        v: Abstract
  url:
    v: https://pubmed.ncbi.nlm.nih.gov/23452809/
    l: https://pubmed.ncbi.nlm.nih.gov/23452809/
web location:
  classifier:
    coding:
      system:
        v: http://terminology.hl7.org/CodeSystem/artifact-url-classifier
        l: artifact-url-classifier
      code:
        v: doi-based
      display:
        v: DOI Based
  url:
    v: https://doi.org/10.1016/j.urology.2012.12.025
    l: j.urology.2012.12.025
classification:
  type:
    coding:
      system:
        v: http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type
        l: cited-artifact-classification-type
      code:
        v: publishing-model
      display:
        v: Publishing Model
      user selected:
        v: false
  classifier:
    coding:
      system:
        v: http://terminology.hl7.org/CodeSystem/citation-artifact-classifier
        l: citation-artifact-classifier
      code:
        v: Print
      display:
        v: Print
      user selected:
        v: false
classification:
  type:
    coding:
      system:
        v: http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type
        l: cited-artifact-classification-type
      code:
        v: chemical
      display:
        v: Chemical
      user selected:
        v: false
  classifier:
    coding: D000726
      system:
        v: https://www.nlm.nih.gov/mesh
        l: mesh
      code:
        v: D000726
      display:
        v: Androgen Antagonists
      user selected:
        v: false

v: NLM

v: D020492

v: Periodical

system:
  v: https://www.nlm.nih.gov/bsd/licensee/elements_descriptions.html#issn
  l: issn
code:
  v: Electronic
display:
  v: Electronic

v: Electronic ISSN Type

system:
  v: http://terminology.hl7.org/CodeSystem/v2-0203
  l: v2-0203
code:
  v: XX
display:
  v: Organization identifier

v: ISOAbbreviation

system:
  v: http://terminology.hl7.org/CodeSystem/v2-0203
  l: v2-0203
code:
  v: XX
display:
  v: Organization identifier

v: ISSN Linking

system:
  v: http://terminology.hl7.org/CodeSystem/v2-0203
  l: v2-0203
code:
  v: XX
display:
  v: Organization identifier

v: Medline Title Abbreviation

system:
  v: http://terminology.hl7.org/CodeSystem/v2-0203
  l: v2-0203
code:
  v: XX
display:
  v: Organization identifier

v: NLM Unique ID

coding: D000813
  system:
    v: https://www.nlm.nih.gov/mesh
    l: mesh
  code:
    v: D000813
  display:
    v: Anilides
  user selected:
    v: false

coding: D000970
  system:
    v: https://www.nlm.nih.gov/mesh
    l: mesh
  code:
    v: D000970
  display:
    v: Antineoplastic Agents
  user selected:
    v: false

coding: D018931
  system:
    v: https://www.nlm.nih.gov/mesh
    l: mesh
  code:
    v: D018931
  display:
    v: Antineoplastic Agents, Hormonal
  user selected:
    v: false

coding: D009570
  system:
    v: https://www.nlm.nih.gov/mesh
    l: mesh
  code:
    v: D009570
  display:
    v: Nitriles
  user selected:
    v: false

coding: D043823
  system:
    v: https://www.nlm.nih.gov/mesh
    l: mesh
  code:
    v: D043823
  display:
    v: Taxoids
  user selected:
    v: false

coding: D014105
  system:
    v: https://www.nlm.nih.gov/mesh
    l: mesh
  code:
    v: D014105
  display:
    v: Tosyl Compounds
  user selected:
    v: false

coding:
  system:
    v: https://www.cas.org/support/documentation/chemical-substances
    l: chemical-substances
  code:
    v: 0F65R8P09N
  user selected:
    v: false
coding: D017273
  system:
    v: https://www.nlm.nih.gov/mesh
    l: mesh
  code:
    v: D017273
  display:
    v: Goserelin
  user selected:
    v: false

coding:
  system:
    v: https://www.cas.org/support/documentation/chemical-substances
    l: chemical-substances
  code:
    v: 15H5577CQD
  user selected:
    v: false
coding: http://id.nlm.nih.gov/mesh/D000077143
  system:
    v: https://www.nlm.nih.gov/mesh
    l: mesh
  code:
    v: D000077143
  display:
    v: Docetaxel
  user selected:
    v: false

coding:
  system:
    v: https://www.cas.org/support/documentation/chemical-substances
    l: chemical-substances
  code:
    v: 35LT29625A
  user selected:
    v: false
coding: D004961
  system:
    v: https://www.nlm.nih.gov/mesh
    l: mesh
  code:
    v: D004961
  display:
    v: Estramustine
  user selected:
    v: false

coding:
  system:
    v: https://www.cas.org/support/documentation/chemical-substances
    l: chemical-substances
  code:
    v: A0Z3NAU9DP
  user selected:
    v: false
coding: C053541
  system:
    v: https://www.nlm.nih.gov/mesh
    l: mesh
  code:
    v: C053541
  display:
    v: bicalutamide
  user selected:
    v: false

type:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type
      l: cited-artifact-classification-type
    code:
      v: mesh-heading
    display:
      v: MeSH heading
artifact assessment:
  l: meshHeading0
  reference:
    v: #meshHeading0
  type:
    v: ArtifactAssessment
    l: ArtifactAssessment

type:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type
      l: cited-artifact-classification-type
    code:
      v: publication-type
    display:
      v: Publication type
classifier:
  coding: D017427
    system:
      v: https://www.nlm.nih.gov/mesh
      l: mesh
    code:
      v: D017427
    display:
      v: Clinical Trial, Phase II
    user selected:
      v: false
classifier:
  coding: D016428
    system:
      v: https://www.nlm.nih.gov/mesh
      l: mesh
    code:
      v: D016428
    display:
      v: Journal Article
    user selected:
      v: false
classifier:
  coding: D013485
    system:
      v: https://www.nlm.nih.gov/mesh
      l: mesh
    code:
      v: D013485
    display:
      v: Research Support, Non-U.S. Gov't
    user selected:
      v: false

type:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type
      l: cited-artifact-classification-type
    code:
      v: knowledge-artifact-type
    display:
      v: Knowledge Artifact Type
    user selected:
      v: false
classifier:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/citation-artifact-classifier
      l: citation-artifact-classifier
    code:
      v: D016428
    display:
      v: Journal Article
    user selected:
      v: false
artifact assessment:
  display:
    v: Classifier added by Computable Publishing LLC

type:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type
      l: cited-artifact-classification-type
    code:
      v: citation-subset
    display:
      v: Citation subset
    user selected:
      v: false
classifier:
  coding:
    system:
      v: https://www.nlm.nih.gov/bsd/licensee/elements_descriptions.html#citationsubset
      l: citationsubset
    code:
      v: IM
    display:
      v: IM
    user selected:
      v: false

complete:
  v: true
entry:
  contributor:
    l: contributor0
    reference:
      v: #contributor0
    type:
      v: Practitioner
      l: Practitioner
    display:
      v: Nakabayashi M
  forename initials:
    v: M
  affiliation:
    display:
      v: Division of Medical Oncology, Department of Medicine, Lank Center for Genitourinary Oncology, Boston, MA 02215, USA.
entry:
  contributor:
    l: contributor1
    reference:
      v: #contributor1
    type:
      v: Practitioner
      l: Practitioner
    display:
      v: Xie W
  forename initials:
    v: W
entry:
  contributor:
    l: contributor2
    reference:
      v: #contributor2
    type:
      v: Practitioner
      l: Practitioner
    display:
      v: Buckle G
  forename initials:
    v: G
entry:
  contributor:
    l: contributor3
    reference:
      v: #contributor3
    type:
      v: Practitioner
      l: Practitioner
    display:
      v: Bubley G
  forename initials:
    v: G
entry:
  contributor:
    l: contributor4
    reference:
      v: #contributor4
    type:
      v: Practitioner
      l: Practitioner
    display:
      v: Ernstoff MS
  forename initials:
    v: MS
entry:
  contributor:
    l: contributor5
    reference:
      v: #contributor5
    type:
      v: Practitioner
      l: Practitioner
    display:
      v: Walsh W
  forename initials:
    v: W
entry:
  contributor:
    l: contributor6
    reference:
      v: #contributor6
    type:
      v: Practitioner
      l: Practitioner
    display:
      v: Morganstern DE
  forename initials:
    v: DE
entry:
  contributor:
    l: contributor7
    reference:
      v: #contributor7
    type:
      v: Practitioner
      l: Practitioner
    display:
      v: Kantoff PW
  forename initials:
    v: PW
entry:
  contributor:
    l: contributor8
    reference:
      v: #contributor8
    type:
      v: Practitioner
      l: Practitioner
    display:
      v: Taplin ME
  forename initials:
    v: ME